Oncolytics Biotech (ONCY) Interest & Investment Income (2009 - 2017)
Oncolytics Biotech's (ONCY) quarterly Interest & Investment Income came in at $14163.0 in Q2 2017, down 60.15% year-on-year from $35537.0 in Q2 2016, and down 60.15% on a QoQ basis from $35537.0 in Q2 2016.
Oncolytics Biotech (ONCY) Interest & Investment Income (2009 - 2017) Analysis & Trends
Oncolytics Biotech (ONCY) has 6 years of Interest & Investment Income data on file, last reported at $14163.0 in Q2 2017.
- On a quarterly basis, Interest & Investment Income fell 60.15% year-over-year to $14163.0 in Q2 2017; TTM through Jun 2017 was $144075.0, a 60.33% increase from a year earlier, with the FY2025 full-year figure at $386000.0, down 60.41% from the prior year.
- Interest & Investment Income for Q2 2017 stood at $14163.0, down from $35537.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for ONCY reached as high as $50253.0 in Q2 2014 and fell as low as $14163.0 in Q2 2017.
- Historically, Interest & Investment Income has averaged $36018.8 across 4 years, with a median of $39829.5 in 2015.
- Across the five-year window, Interest & Investment Income slipped 12.2% in 2015 and plunged 60.15% in 2017, its largest moves.
- Year by year, Interest & Investment Income stood at $50253.0 in 2014, then decreased by 12.2% to $44122.0 in 2015, then dropped by 19.46% to $35537.0 in 2016, then sank by 60.15% to $14163.0 in 2017.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $14163.0 in Q2 2017, $35537.0 in Q2 2016, and $44122.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Oncolytics Biotech | 76.93 Mn | 76.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 14,163.00 |
| Jun 30, 2016 | 35,537.00 |
| Jun 30, 2015 | 44,122.00 |
| Jun 30, 2014 | 50,253.00 |
| Dec 31, 2010 | -40,052.00 |
| Sep 30, 2010 | -6.60 Mn |
| Jun 30, 2010 | -6.58 Mn |
| Mar 31, 2010 | -9,819.00 |
| Dec 31, 2009 | -5,225.00 |
| Sep 30, 2009 | -3,360.00 |
| Jun 30, 2009 | -3,732.00 |
| Mar 31, 2009 | -17,124.00 |